Welcome

BioInvent is a research-based pharmaceutical company developing innovative antibody drugs to target diseases with unmet clinical need. The Company's pipeline currently includes three product candidates for the treatment of cancer.

Meet us

29 April - 3 May, 2013, 9th Annual PEGS Summit, Boston, USA

Our Pipeline

BioInvent develops antibody-based drugs to tackle conditions where there is a significant need for new treatments. We currently have three antibody therapeutics in development. Find out more »

Press Releases

Latest Share Price

Clinical Trials

BioInvent is currently running early-stage clinical trials with its products. Click here to find out more »